Product
Ropinirole
2 clinical trials
3 indications
Indication
Parkinson's diseaseIndication
hyperprolactinemiaIndication
ProlactinomaClinical trial
An Open-Label, Relative Bioavailability Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Ropinirole Implants in Patients With Parkinson's Disease Switched From Oral Immediate-Release Ropinirole While on L-DopaStatus: Terminated, Estimated PCD: 2018-05-22
Clinical trial
Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole: A Dose Escalation Study of Efficacy and TolerabilityStatus: Completed, Estimated PCD: 2020-11-05